March 3 () - Diagnostics firm Droplet Biosciences said on Tuesday it is collaborating with Nvidia to use the chipmaker's AI ...
Researchers uncover how distinct cell populations and fibrotic signals drive permanent scarring after rotator cuff ...
Tempus AI's diagnostics arm is surging in 2025 as precision oncology testing, MRD adoption, AI-driven genomic tools and the Ambry Genetics acquisition expand capabilities.
Medical Device Network on MSN
Droplet improves genomic analysis speed using NVIDIA Parabricks software
The adoption of GPU-accelerated software now enables significant time savings.
A new whole genome platform integrates on-flow cell library prep and advanced informatics to deliver comprehensive variant ...
A new AI-based method reconstructs spatial information about where immune cells were originally located in an organ, even after these cells have been removed from the tissue and analyzed individually.
Droplet Biosciences uses lymph fluid and NVIDIA Parabricks to detect residual cancer faster and cut analysis time and costs.
Droplet reduces genomic analysis time using NVIDIA Parabricks, enabling rapid turnaround of test results CAMBRIDGE, Mass., March 3, 2026 /PRNewswire/ -- Droplet Biosciences, a diagnostics company ...
Are you attending the ABRF Annual Meeting 2026? Here are the breakout sessions and workshops you won’t want to miss.
Health systems move beyond the pilot era over health systems to integrate AI into workflows with governance for safe, compliant adoption.
Strategic partnership delivers scalable, CLIA-certified capillary blood testing to support rural Medicaid programs and ...
Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results